Dialogue Health Technologies completes initial public offering

On March 30, 2021, Dialogue Health Technologies Inc. ("Dialogue") announced the closing of its previously announced initial public offering pursuant to which it sold an aggregate of 8,334,000 common shares at a price of C$12.00 per share, for total gross proceeds of approximately C$100 million.

The offering was made through a syndicate of underwriters led by National Bank Financial Inc., RBC Capital Markets, Scotiabank and TD Securities Inc. as joint bookrunners and including CIBC World Markets Inc., Desjardins Securities Inc., Canaccord Genuity Corp., iA Private Wealth Inc., INFOR Financial Inc. and Laurentian Bank Securities Inc.

Certain shareholders of Dialogue also granted the underwriters an over-allotment option exercisable, in whole or in part, at any time and from time to time for a period of 30 days after closing of the offering, to purchase up to 1,250,100 common shares (representing 15% of the aggregate number of common shares sold in the base offering) at the offering price for aggregate gross proceeds to the selling shareholders of approximately C$15 million. The exercise in full was announced on April 15, 2021. Dialogue will not receive any proceeds from this secondary offering.

Further information can be found on Canada Newswire’s website.

Dialogue is Canada's premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care.